Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Allied Corp.

Market Cap 1.3M 1.12M 1.03M 971K 1.82M 123M 1.84M 12.22M 4.76M 60.36M 4.89M 4.79M 209M P/E Ratio 2023
-2.13x
P/E Ratio 2024 -2.52x
Enterprise Value 7.55M 6.51M 5.99M 5.63M 10.56M 714M 10.68M 70.81M 27.59M 350M 28.34M 27.74M 1.21B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
52.84%
Yield 2023 *
-
Yield 2024 -
Current year 0
Extreme 0
0.01
1 year 0
Extreme 0
0.01
3 years 0
Extreme 0
0.28
5 years 0
Extreme 0
2.15
10 years 0
Extreme 0
4.5
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - 2020-05-01
Director/Board Member - -
Director/Board Member - 2024-10-20
Date Insider Type Main position Quantity % Market Cap.
23-04-24Buy

Director

80,000 0.0824%
20-09-21Other

Chief Executive Officer

0 0%
20-09-21Buy

Chief Executive Officer

10,000 0.0118%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 117
-0.95%-13.21%+314.07%+13.12% 2.58B
-4.67%-18.61%+156.06%+135.00% 1.9B
-7.27%-13.61%-2.20%+180.18% 553M
+5.26%+13.64%+25.00%0.00% 51.88M
Average -1.53%-5.94%+123.23%+82.07% 1.02B
Weighted average by Cap. -2.96%-15.89%+217.77%+76.62%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.82 0.1 0.68 0.26 3.34 0.27 0.26 11.57 0.1 0.08 0.08 0.07 0.13 9.09 0.14 0.9 0.35 4.45 0.36 0.35 15.43
Net income -10.68M -9.2M -8.47M -7.95M -14.93M -1.01B -15.09M -100M -39M -494M -40.06M -39.21M -1.71B -3.98M -3.43M -3.16M -2.96M -5.56M -376M -5.62M -37.29M -14.53M -184M -14.92M -14.61M -638M
Net Debt 5.65M 4.87M 4.49M 4.21M 7.91M 534M 7.99M 53M 20.65M 262M 21.21M 20.76M 907M 6.25M 5.38M 4.96M 4.66M 8.74M 591M 8.83M 58.59M 22.82M 289M 23.45M 22.95M 1B
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-
  1. Stock Market
  2. Stocks
  3. ALID Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!